baber/WOPTO huggingface dataset:
Patent CA-2505775-A1 (CA)
Title: Entrainement anti-tachycardie multisite a periode de retard programmable
Inventor: BURNES JOHN E
IPC: A61N1/362
Filed: 2003-10-27
Abstract: L'invention concerne des techniques pour administrer des thérapies d'entraînement anti-tachycardie à un coeur. L'invention concerne un dispositif médical destiné à l'administration d'une thérapie anti-tachycardie comprenant au moins deux électrodes situées à proximité ou à l'intérieur des ventricules et/ou au moins deux électrodes situées à proximité ou à l'intérieur de l'atrium du coeur destinées à traiter la tachycardie ventriculaire et/ou atriale. Au moins certaines impulsions à l'intérieur de séquences d'impulsions d'une thérapie sélectionnée peuvent être administrées par l'intermédiaire de chacune des deux électrodes. Le temps d'administration desdites impulsions par une électrode particulière peut être basé sur une longueur de cycle programmée entre des impulsions consécutives à l'intérieur des périodes de séquence et des périodes de retard qui sont programmées pour chaque électrode pour chaque impulsion. Ainsi, différentes électrodes peuvent administrer la même impulsion à l'intérieur d'une séquence à des moments différents, tout en améliorant l'efficacité des thérapies d'entraînement anti-tachycardie.
Patent CA-2506097-A1 (CA)
Title: Compression release mechanism
Inventor: STERR RANDALL E
IPC: F01L13/08
Filed: 2000-06-27
Abstract: A compression release mechanism for use in a single or multi-cylinder engine to make the engine easier to hand start. The assembly includes a compression release shaft disposed substantially within the camshaft. The compression release shaft is formed in at least two segments and can therefore be formed accurately, repeatedly and cost effectively using powder metal technology. Consequently, the weight of the flyweight member that is attached to the compression release shaft can be accurately controlled, thereby allowing the compression release mechanism to disengage at a precisely known rotational velocity of the camshaft. The compression release shaft may engage one or more valve actuation devices, which in turn force exhaust valves open during starting engine speeds. The compression release mechanism is conveniently contained within the housing by a housing wall bearing against the flyweight member and a cam bearing against an end of the compression release shaft. These bearing surfaces also hold the compression release shaft segments together.
Patent CA-2507126-A1 (CA)
Title: Arrangement of an inductive coupler for power line communications
Inventor: CERN YEHUDA
IPC: H01F38/20
Filed: 2003-11-24
Abstract: There is provided an arrangement of components for use in a power line communication system. The arrangement includes (a) an inductive coupler (100) having a core (105) with an aperture (110) through which a coaxial power cable (125) is routed, where the coaxial power cable has a center conductor (130) and an outer conductor (140); and (b) a lead (145) being routed through the aperture, where the lead connects the outer conductor to a termination.
Patent CA-2507300-A1 (CA)
Title: Method and apparatus for high throughput catalysts screening and optimization
Inventor: FUNG SHUN CHONG
IPC: C40B60/14
Filed: 2003-11-21
Abstract: The present invention relates to an apparatus and a process for the high- throughput, quick screening, optimization, regeneration, reduction and activation of catalysts. More specifically, the present invention is a metho d and apparatus to quickly screen, optimize and regenerate multiple fast deactivating catalysts while maintaining a predefined range of time-on-strea m.
Patent CA-2508523-A1 (CA)
Inventor: KOSYACHKOV ALEXANDER
IPC: C23C14/06
Filed: 2003-12-04
Abstract: The invention is a novel sputter target and deposition method for multi-element thin film phosphors for thick film dielectric electroluminescent displays in which the deposited phosphors provide a high luminance and colors required for TV applications. The method comprises sputtering a single composite target in a low pressure sputtering atmosphere that comprises gases containing reactive species and non-reactive species. The composite target comprising a matrix phase and an inclusion phase, or two matrix phases, wherein one of the phases comprises one or more metallic elements that contribute to the composition of the phosphor and the other of the phases comprises the remaining elements that contribute to the composition of the phosphor. In the method the pressure of the reactive species within the sputtering atmosphere is varied to control the sputtering rate of the matrix and inclusion phases of the composite target to cause the ratio of the elements in the two phases to deposit in a desired ratio as a phosphor film on the substrate.
Patent CA-2509053-A1 (CA)
Inventor: CHERN SHIANN-TORNG
IPC: A45D29/05
Filed: 2005-05-19
Abstract: A fingernail filing assembly includes a power device, a rotation seat having a hollow mounting collar extending from an inner face of the rotation seat to correspond to and to receive therein the axle and a grinding stone securely mounted an top of the rotation seat and a cover threadingly connected to the power device to sandwich therebetween the rotation seat with the power device. The cover has at least one opening defined through the cover to provide an access to the grinding stone such that a fingernail is able to extend into the at least one opening to have the fingernail filed by the rotating grinding stone.
Patent CA-2512492-A1 (CA)
Inventor: BJORGE JEFFREY D
IPC: C07H21/00
Filed: 2005-06-16
Abstract: Methods and reagents for reducing expression of proteins involved in intracellular signalling are disclosed. Specifically, siRNA sequences are provided for reducing expression of Src, stat3, and c-myc gene products. Combination treatments are disclosed for inhibiting cell proliferative pathways, and for reducing tumor growth in breast and colon cancer.
Patent CA-2513192-A1 (CA)
Title: Nucleotide sequence coding for a tolc and a defined amino acid sequence
Inventor: GOEBEL WERNER
IPC: A61P31/04
Filed: 2003-02-13
Abstract: The invention relates to a nucleotide sequence coding for a TolC and a defined amino acid sequence, said defined amino acid sequence being inserted in the permissive, membrane-external area of the TolC, and several uses thereof, particularly bacteria containing such a nucleotide sequence.
Patent CA-2514796-A1 (CA)
Title: Aluminum-silicon alloy having reduced microporosity
Inventor: DONAHUE RAYMOND J
IPC: C22C21/04
Filed: 2005-08-03
Abstract: An aluminum silicon die cast alloy having a very low iron content and relatively high strontium content that prevents soldering to dies into die casting process. The alloys of the present invention also have a modified eutectic silicon and modified iron morphology, when iron is present, resulting in low microporosity and high impact properties. The alloy comprises 6-22% by weight silicon, 0.05 to 0.20%  by weight strontium and the balance aluminum. Preferably, the alloy of the present invention contains in weight percent: 6-20% silicon, 0.05-0.10% strontium, 0.40% maximum iron and most preferably 0.20% maximum iron, 4.5% maximum copper, 0.50% maximum manganese, 0.60% maximum magnesium, 3.0% maximum zinc, balance aluminum. On cooling from the solution temperature, the strontium serves to modify the eutectic silicon structure as well as create an iron phase morphology change if iron is present, facilitating feeding through the aluminum interdendritic matrix. This, in turn, creates a finished die cast product with extremely low levels of microporosity defects. The strontium content also appears to create a non-wetting monolayer of strontium atoms on the surface of a molten casting, preventing die soldering, even at very low iron contents. The alloy may be used to cast any type of object and is particularly suited for casting outboard marine propellers, driveshaft housings, gear case housings, Gimbel rings and engine blocks.
Patent CA-2517187-A1 (CA)
Title: Transmitter loops in series for geophysical surveys
Inventor: BERUBE PIERRE
IPC: G01V3/11
Filed: 2005-08-25
Abstract: The invention relates to a transmitter loop configuration used for ground and downhole electromagnetic geophysical surveys. The loop wire is spread out on the ground surface in such a way as to form several subset loops in series. Each subset loop can be juxtaposed to each other or separated by a fixed distance. The contribution of each subset to the primary electromagnetic field is improved in intensity and vector orientation so as to energize more efficiently buried geological conductors. This design generates a strong sub-horizontal primary field in an in-loop zone of the global loop. Any sub-vertical conductor buried under this in-loop zone will be maximum-coupled and will generate a secondary electromagnetic field detectable by a receiver device. This invention includes the possibility of using a combination a several pairs of loops.
Patent CA-2519797-A1 (CA)
Title: Low molecular weight hyaluronic acid for the treatment of nerve damage
Inventor: ASARI AKIRA
IPC: A61K31/70
Filed: 2004-03-25
Abstract: It is intended to provide a remedy for nerve damage caused by spinal injury, nerve trauma or the like which contains, as the active ingredient, a low-molecular weight saccharide at least having glucuronic acid and/or N-acetylglucosamine as the constituting sugar(s) or a pharmaceutically acceptable salt thereof. Preferably, a remedy for nerve damage which contains, as the active ingredient, a low-molecular weight hyaluronic acid (still preferably hyaluronic acid disaccharide to hyaluronic acid 2500-saccharide, still preferably hyaluronic acid disaccharide to hyaluronic acid 50-saccharide, particularly preferably hyaluronic acid tetrasaccharide) or a pharmaceutically acceptable salt thereof.
Patent CA-2521451-A1 (CA)
Title: Tete de coupe forestiere multifonctionnelle avec bras accumulateurs
Inventor: LAVOIE SYLVAIN
IPC: A01G23/091
Filed: 2005-09-28
Abstract: Une tête de coupe forestière multifonctionnelle comportant un arbre de positionnement, une structure de support liée de façon pivotante à l'arbre d e positionnement, un joint hydraulique et électrique rotatif relié à la structure de support, un système de bras accumulateurs relié à une table de roulement à billes avec une couronne d'entraînement et une arche de basculement pour la tête multifonctionnelle reliée au système de bras accumulateurs par un joint oscillant. Une interface entre le joint oscillant et le système de bra s accumulateurs est placée à une certaine distance par rapport à l'axe de rotation central du joint hydraulique rotatif afin d'amortir le mouvement oscillant produit par la tête de tronçonnage et de transformation.
Patent CA-2523246-A1 (CA)
Inventor: OMIDIAN HOSSEIN
IPC: C08J9/28
Filed: 2004-04-14
Abstract: The present invention features a method for the formation of superporous hydrogels using an ion-equilibration tech-nique. Anionic polysaccharides are included in the hydrogel reaction mixture and cations are introduced either during or after hydrogel formation. Properties of the resulting hydrogel can be subsequently adjusted by treating the cation complexed gel with a different cation or cation mixture under equilibrating conditions. It has been found that by properly adjusting the cations and the sequence in which they are used in the equilibration process, superporous hydrogels can be formed that are highly absorbent while maintaining favorable structural properties, including strength, ruggedness, and resiliency. It has also been found that applying ap-propriate dehydration conditions to them after their formation can further stabilize the superporous hydrogels formed by the method of the invention.
Patent CA-2525449-A1 (CA)
Inventor: ALIHODZIC SULEJMAN
IPC: A61K31/04
Filed: 2004-05-11
Abstract: The present invention relates to 14- or 15-membered macrolides substituted at the 4" position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
Patent CA-2526822-A1 (CA)
Inventor: MANNUELLA EUGENE J
IPC: F16L15/04
Filed: 2005-11-14
Abstract: Method of sealing one or more threaded connections between ends of a pair of tubular members configured to be rotatably threadably engageable. One of the members as an externally-threaded portion, with the other one having an internally-threaded portion. One of the threaded portions has a radial groove formed therein which is configured to receive a seal ring for sealing the connection. The groove of the one portion defines a void with the other portion, with the seal ring being compressed into the void by the engagement of the threaded ends of the members. The method involves determining a deformed axial cross-sectional geometries of the ends, mathematically revolving the deformed axial cross-sectional geometries to generate a corresponding solid of revolution, calculating the volume of the void by subtracting the open of the solid volumes from the other, and sizing the seal ring to overfill the void by a specified amount.
Patent CA-2527129-A1 (CA)
Title: Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
Inventor: KIM SUN OK
IPC: C07D405/14
Filed: 2004-05-28
Abstract: The present invention relates to benzopyran derivatives substituted with a benzimidazole derivative, or pharmaceutically acceptable salts thereof, a preparation method of the same and pharmarceutical compositions containing them. Benzopyran derivatives substituted with a benzimidazole derivative, represented in Formula (1), have the function of protecting heart from ischemia-reperfusion without side effect like vasodilation, so that a pharmaceutical composition containing benzopyran derivatives substituted with a benzimidazole derivative or pharmaceutically acceptable salts thereof of the present invention as an effective ingredient can be effectively used for the protection of tissues influenced by ischemia-reperfusion, for example, for the protection of heart, nervous cells, brain, retinal cells, storage organs, etc.  and for the treatment of diseases caused by ischemia-reperfusion.
Patent CA-2528189-A1 (CA)
Inventor: WEYHRAUCH ERNEST C
IPC: H05B39/00
Filed: 2005-11-24
Abstract: A lamp includes a voltage conversion circuit that converts a line voltage at a lamp terminal to a load voltage usable by a light emitting element of the lamp. The voltage conversion circuit is housed entirely within a base of the lamp and includes a silicon diode for alternating current (SIDAC) that is connected in series between the lamp terminal and the light emitting element and that operates as a bilateral voltage triggered switch to clip the load voltage.
Patent CA-2528553-A1 (CA)
Title: Ergonomic handle attachment for welding torch
Inventor: ZAMUNER FRANK
IPC: B23K9/32
Filed: 2005-12-01
Abstract: An ergonomic handle attachment to be used with a welding torch handle, the attachment has an attachment portion having a first wall that is selectively attached to a wall of the handle and a second wall which extends from the first wall and is selectively received by an opening in the wall of the handle. A locking member is slidably received within the opening of the second wall and the wall of the handle when the opening of the second wall and the opening of handle are substantially aligned with each other.
Patent CA-2528767-A1 (CA)
Inventor: KIMURA TETSUYUKI
IPC: H02K7/18
Filed: 2004-01-07
Abstract: A generator and a power supply for use therein, wherein cost of the generator itself is reduced by turning attention to the structure of the generator, or power generation cost is reduced by turning attention to the performance of the generator.
Patent CA-2529188-A1 (CA)
Inventor: ABDULIJALIL HASSAN
IPC: B05B1/34
Filed: 2004-07-02
Abstract: Nozzle arrangement for generating a spray of fluid comprise a body defining a flow passageway (10), which receives fluid from a supply via an inlet (11 or 12) and is configured to present a plurality of chambers (13, 16, 20) separated by constrictions such as (15, 17). The chambers include expansion chambers such as (13, 20), and the constrictions may be associated with respective convergent and divergent passage sections (14, 19). The inner surfaces of the passageway or chambers, may be provided with small scale structures such as grooves, ribs, pits or protrusions.
Patent CA-2532154-A1 (CA)
Title: Quinoline derivates and their use in therapy
Inventor: WILLIS PAUL
IPC: A61P11/00
Filed: 2004-07-21
Abstract: The invention provides compounds of formula (I) wherein n, p, q, X, R1, R2, R3, R4, R5 and R6 are as defined in the specification; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Patent CA-2532580-A1 (CA)
Title: System and method for generating code in designing a computer program using rules and procedures
Inventor: O'BRIEN WAYNE PATRICK
IPC: G06F9/44
Filed: 2004-07-14
Abstract: Designing a computer program includes accessing invariant domain rules and displaying variable business rules. One or more business rules are selected in response to a user selection and are customized. The business rules are associated with a procedure, and the domain rules are associated with the procedure. A model representing the procedure is displayed, and a code corresponding to the procedure is generated to design a computer program.
Patent CA-2535221-A1 (CA)
Title: Chimeric gabab receptor
Inventor: SMANS KARINE ALFONSINE ASTRID
IPC: C07D513/00
Filed: 2004-09-03
Abstract: The present invention provides an isolated GABAB receptor protein comprising at least one GABABR1a subunit and at least one GABABR2a subunit, characterized in that said GABAB receptor has one high affinity agonist binding site and one low affinity agonist binding site. In particular the isolated recombinant GABAB receptor protein expressed by the hGABABR1a/GABABR2 CHO cell line deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) as CHO-K1 h-GABA-b R1a/R2 clone on August 22,2003 with the accession number LMBP  6046CB. It is thus an object of the present invention to provide the hGABABR1a/GABABR2 CHO cell line deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) as CHO-KI h-GABA-b R1a/R2 clone on August 22, 2003 with the accession number LMBP 6046CB. The invention also provides the use of the aforementioned cell lime in a method to identify GABAB receptor agonists using a functional or a binding assay.
Patent CA-2536839-A1 (CA)
Title: Lid for a container
Inventor: TIPPMANN VINCENT P SR
IPC: B65D43/16
Filed: 2004-08-27
Abstract: A lid (10) for a container includes a side element (15) extending from a front of the lid to a rear of the lid. A fulcrum point (14) is formed at one end of the side element and is disposed adjacent to a rear of the lid. A rear surface (17) of the lid includes a portion that projects upwardly and rearwardly to a furthermost rear point (16) that is displaced rearwardly a predetermined distance relative to the fulcrum point. A counter-balance weight (18) is positioned on the furthermost rear point of the lid. Wherein when the lid is raised, the weight of the lid and the counter-balance weight provide a force for raising the lid and to selectively maintain the lid in an open position.  When the lid is lowered, the weight of the lid and the counter-balance weight provide a force for closing the lid.
Patent CA-2537123-A1 (CA)
Inventor: VARGA MARTON
IPC: C07D409/12
Filed: 2004-08-27
Abstract: The invention relates to new compounds of the general formula (I), which are strong DPP-IV enzyme inhibitors.
Patent CA-2542142-A1 (CA)
Title: Methods and compositions using adiponectin for treatment of cardiac disorders and for stimulation of angiogenesis
Inventor: WALSH KENNETH
IPC: A61K39/00
Filed: 2004-10-08
Abstract: We have surprisingly discovered that adiponectin regulates angiogenesis and have shown that adiponectin is an effective agent at treating cardiac disorders. As a result of this discovery, the present invention provides methods for treatment of cardiac disorders and methods for stimulation of angiogenesis in tissues using adiponectin. In one preferred embodiment, the methods of the invention are used to treat complications of diabetes, such as ischemic limbs and hypertrophic cardiomyopathy.
Patent CA-2544714-A1 (CA)
Inventor: MUNJE ARUN
IPC: H04L29/12
Filed: 2006-04-24
Abstract: The present disclosure discloses a scheme for sharing data among multiple applications within a mobile communications device. The scheme involves performing a remote database inquiry with respect to a remote database accessible via a wireless packet data service network, wherein the remote database inquiry is performed as part of a first application available on the mobile communications device. The information resulting from the remote database inquiry is then stored in a local common database object that is accessible to a second application available on the mobile communications device.
Patent CA-2546899-A1 (CA)
Title: Process for the preparation of tubulin inhibitors
Inventor: AFRAGOLA JAY THOMAS
IPC: C07D487/04
Filed: 2004-12-07
Abstract: The present invention provides a process for the preparation of 6-[(substituted) phenyl]-triazolopyrimidine dicarboxylic acid salt and as a hydrated salt having the structural formula (I) wherein: R1 is CF3 or C2F5; R2 is H or C1-C3 alkyl; n is an integer of 2, 3, or 4; X is Cl or Br; R3 and R4 are each independently H or C,-C3 alkyl; or R3 and R4 when optionally taken together with the nitrogen atom to which each is attached form a 4 to 6 membered saturated heterocyclic ring having 1-2 nitrogen atoms and 0-1 oxygen atoms or 0-1 sulfur atoms, and optionally substituted with R5; R5 is C,-C3 alkyl; wherein the dotted line is an optional bond.
Patent CA-2547750-A1 (CA)
Title: Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2
Inventor: LINNEN JEFFREY M
IPC: C12P19/34
Filed: 2004-12-16
Abstract: Compositions, methods and kits for detecting the nucleic acids of HIV-1, HIV - 2, or the combination of HIV-1 and HIV-2. Particularly described are oligonucleotides that are useful as hybridization probes and amplification primers, including cross-reacting hybridization probes and cross-reacting amplification primers, for detecting very low levels of viral nucleic acids.
Patent CA-2554616-A1 (CA)
Title: Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
Inventor: PIEPER MICHAEL P
IPC: A61P25/24
Filed: 2005-01-11
Abstract: The invention relates to a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (1), and at least one dopamine agonist or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (2), and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
Patent CA-2554841-A1 (CA)
Inventor: ASHBY DARYL
IPC: E03F7/00
Filed: 2006-08-02
Abstract: A method of regulating flow through a liquid distribution system. A first step involves connecting at least one flow control tank to the liquid distribution system. A second step involves connecting to an outlet of the at least one flow control tank, one of a flow control valve or flow control pump adapted to selectively control a release of liquids from the flow control tank. A third step involves positioning flow sensors at selected locations along the liquid distribution system. A fourth step involves connecting an electronic controller to the flow sensors and to the flow control valve or flow control pump. The electronic controller is adapted to control the release of liquid from the flow control tank via the flow control valve or flow control pump into the liquid distribution system depending upon data from the flow sensors concerning current flow conditions.